Novartis Investigative Site

Torrington, Connecticut 06790

0 studies enrolling now · 1 studies all time

What they study most

Non-Hodgkin's Lymphoma

Studies at this site

• Single Agent Ofatumumab Vs. Single Agent Rituximab in Indolent B-Cell Non Hodgkin Lymphoma Relapsed After Rituximab-Containing Therapy — Stopped early